ERBB2 and breast carcinoma: We reproduced these findings in an independent Her2-negative ER+ cohort from a large dataset, i.e., METABRIC (Molecular Taxonomy of Breast Cancer International Consortium; ref. 24), a landmark genomic and transcriptomic study of 2000 individual breast tumors (Figure 3, F and G).